PF-Atlas › Clinical Trials › NCT02227394

Study to Compare the Effects of Z7200 And Symbicort® Turbohaler on Respiratory Imaging Parameters in Asthmatic Patients

Z7200 · Phase 2

Registry ID

NCT02227394

Phase

Phase 2

Status

Completed

Drug / intervention

Z7200

Sponsor

Zambon SpA

Start

2014-08

About this trial

Z7200 is evaluated in NCT02227394, a Phase 2 idiopathic pulmonary fibrosis study sponsored by Zambon SpA. Current status: Completed.

View NCT02227394 on ClinicalTrials.gov →

Explore related

All Z7200 trials All IPF trials

Medical disclaimer. This page summarizes public trial data for NCT02227394 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.